Search for: "MEDICAL GROUP Z" Results 101 - 120 of 183
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jan 2015, 8:09 am
| The future of private copy levies in the EU | Kat-tips for IP conferences | Appeals at EPO: beware of what you ask | EPO BoA’s independence | CJEU in International Stem Cell Corporation | IPKat’s 2014 Copyright Awards | Waze and innovation drawbacks | Battistelli and Kongstad interviewed | Porcelains that copy advertising | Jay-z’s “Oh” sample gets its decision, yo. [read post]
12 Jan 2015, 1:39 am
| The future of private copy levies in the EU | Kat-tips for IP conferences | Appeals at EPO: beware of what you ask | EPO BoA’s independence | CJEU in International Stem Cell Corporation | IPKat’s 2014 Copyright Awards | Waze and innovation drawbacks | Battistelli and Kongstad interviewed | Porcelains that copy advertising | Jay-z’s “Oh” sample gets its decision, yo. [read post]
11 Nov 2014, 6:30 am by Michael B. Stack
  At the same time, the law firm of X,Y, & Z is representing a number of these same claimants. [read post]
19 Aug 2014, 9:01 pm by Joanna L. Grossman
A woman has recently filed a lawsuit claiming that she gave birth to Beyonce and Jay-Z’s daughter, Blue Ivy Carter, and should be recognized as the child’s legal mother. [read post]
21 Jul 2014, 2:08 pm
As the group of people were in the elevator, it went into a free-fall due to overcrowding. [read post]
30 Jun 2014, 3:45 pm
Atypical microbacterium are a group of bacteria in the same family as the bacterium that causes tuberculosis. [read post]
26 Jan 2014, 9:01 am
  Based in Santa Clarita, California the foundation is a non-profit medical research foundation which commenced patent infringement proceedings against Cochlear in December 2007. [read post]
28 Nov 2013, 4:36 am by Jon Gelman
While health insurance and access to medical care help reduce risks of financial catastrophe and can improve the health of those suffering from illness, health care alone cannot ensure good health and prevent the onset of disease. [read post]
7 Nov 2013, 11:45 am by EEM
'Hearing the Right Gaps': Enabling and Responding to Disclosures of Sexual Violence within the UK Asylum Process, Research Paper no. 2013/36 (Edinburgh School of Law, Oct. 2013) [text via SSRN] "Legal and Medical Bases for Granting Asylum in the USA to Women with Female Genital Mutilation: A Systematic Review," The Lancet, vol. 381 (Oct. 2013) [free full-text, with registration] Missing the Mark: Decision Making on Lesbian, Gay (Bisexual, Trans and Intersex) Asylum Claims (UK Lesbian… [read post]
22 Sep 2013, 8:35 am by Susan Schneider
This year’s LL.M. class is a diverse and talented group of attorneys with law degrees from the UCLA, the University of Colorado, Indiana University, Vermont Law School, the University of Londrina in Brazil, the University of Arkansas at Little Rock (William Bowen School of Law), Arizona State University, the University of South Carolina, and, our own University of Arkansas School of Law. [read post]
14 Aug 2013, 6:52 pm
The good news is that attorney Michael Kraut of the Kraut Law Group is available to help you approach your case. [read post]
23 May 2013, 5:00 am by Bexis
  That’s an important issue, since many drug and device company have outside physician advisory groups. [read post]
15 Apr 2013, 1:40 pm by Schachtman
  In terms of survival at five years, the earlier trial showed survival in the therapy group at 77.8%, compared to 16.7% in the control groups, p = 0.009. [read post]
28 Mar 2013, 3:13 am
So manufacturers coin their names for that group, rather than the general consumer. [read post]
21 Sep 2012, 11:57 am by Victoria VanBuren
I wonder if you would consider being part of our medical staff executive committee as part of a purchase package? [read post]
28 Aug 2012, 9:23 am by Jonathan Brun
So far, we have come up with the following list of OSHA 29CFR 1910 parts, thanks mainly to the Isosceles Group in Boston who have experts on the ground and who know OSHA like the back of their hand. [read post]
17 Aug 2012, 9:15 am
The crux of the present issue is whether limiting a medical use claim by specifying that the individual has biomarker Z will confer novelty where the prior art is silent about patients having biomarker Z, but where patients with biomarker Z will inevitably have been treated, i.e. does limiting a medical use claim to a patient group that overlaps with, or is within, the prior art patient group, make the claim novel? [read post]